Andorra vs South Sudan: The number of people with susceptibility test result for rifampicin
Andorra
2
in 2021
South Sudan
0
in 2021
Andorra rank
143rd
South Sudan rank
146th
The number of people with susceptibility test result for rifampicin over time
- Andorra
- South Sudan
How they compare
Andorra currently reports 2 against 0 in South Sudan, a difference of 2.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was South Sudan ahead.
Andorra ranks 143rd and South Sudan ranks 146th of 155 countries.
South Sudan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Andorra | South Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.33 | 77.67 | 76.33 | South Sudan |
| 2020s | 1.5 | 164.5 | 163 | South Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Andorra or South Sudan?
- Andorra, at 2 against 0 in South Sudan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Andorra and South Sudan?
- 2, with Andorra ahead.
- How many years of comparable data are there for Andorra and South Sudan?
- 5 years are reported by both, from 2017 to 2021.
- How do Andorra and South Sudan rank globally for the number of people with susceptibility test result for rifampicin?
- Andorra ranks 143rd and South Sudan ranks 146th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.